comments
Respond
Comment on the article
Add a citation
Reply with an article
Start a new topic
Edit
Edit article
Delete article
Share
Invite
Link
Embed
Social media
Avatar
View
Graph
Explorer
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 levels
Load all levels
All
Dagre
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 level
Load all levels
All
Tree
SpaceTree
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Radial
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Box
Focus
Expanding
Down
Up
All
Down
Article ✓
Outline
Document
Down
All
Page
Canvas
Time
Timeline
Calendar
Updates
Subscribe to updates
Get updates
Past 24 hours
Past week
Past month
Past year
Pause updates
Contact us
Commercial Serological Tests for TB
RELATED ARTICLES
Explain
⌅
Controlling Infectious Diseases
Controlling Infectious Diseases☜Mapping the issues around endemic diseases—such as malaria, measles, influenza, HIV, Dengue and West Nile Virus—with the aims of identifying improved control strategies and of providing insights into to the work of mathematical biologists, epidemiologists and public health officials in this field.☜F1CEB7
⌃
Diseases
Diseases☜☜FFB597
⌃
TB
TB☜The Wikipedia page on Tuberculosis is embedded in the Details, and will be updated whenever the Wikipedia page updates.☜D3B8AB
⌃
Diagnosis of Tuberculosis
Diagnosis of Tuberculosis☜☜FFB597
■
Commercial Serological Tests for TB
Commercial Serological Tests for TB☜☜59C6EF
↳
Adverse impact on patient-safety
Adverse impact on patient-safety☜High proportions of false-positive and false-negative results adversely impact patient safety.☜EF597B
↳
Imprecise findings
Imprecise findings☜Commercial serological tests for TB provide imprecise findings.☜EF597B
↳
Inconsistent findings
Inconsistent findings☜Commercial serological tests for TB provide findings☜EF597B
↳
Patient-important outcomes aren't improved
Patient-important outcomes aren't improved☜There is no evidence that existing commercial serological assays improve patient-important outcomes.☜EF597B
□
Scenario of extra testing (dr-to-dr) in targeted populatn + early Tx
Scenario of extra testing (dr-to-dr) in targeted populatn + early Tx☜☜FFB597
□
Graph of this discussion
Graph of this discussion☜Click this to see the whole debate, excluding comments, in graphical form☜dcdcdc
Enter the title of your article
Enter a short (max 500 characters) summation of your article
Click the button to enter task scheduling information
Open
Enter the main body of your article
Prefer more work space? Try the
big editor
Enter task details
Message text
Select assignee(s)
Due date (click calendar)
RadDatePicker
RadDatePicker
Open the calendar popup.
Calendar
Title and navigation
Title and navigation
<<
<
November 2024
>
<<
November 2024
S
M
T
W
T
F
S
44
27
28
29
30
31
1
2
45
3
4
5
6
7
8
9
46
10
11
12
13
14
15
16
47
17
18
19
20
21
22
23
48
24
25
26
27
28
29
30
49
1
2
3
4
5
6
7
Reminder
No reminder
1 day before due
2 days before due
3 days before due
1 week before due
Ready to post
Copy to text
Enter
Cancel
Task assignment(s) have been emailed and cannot now be altered
Lock
Cancel
Save
Comment graphing options
Choose comments:
Comment only
Whole thread
All comments
Choose location:
To a new map
To this map
New map options
Select map ontology
Options
Standard (default) ontology
College debate ontology
Hypothesis ontology
Influence diagram ontology
Story ontology
Graph to private map
Cancel
Proceed
+Comments (
0
)
- Comments
Add a comment
Newest first
Oldest first
Show threads
+Citations (
0
)
- Citations
Add new citation
List by:
Citerank
Map
+About
- About
Entered by:-
David Price
NodeID:
#113929
Node type:
Position
Entry date (GMT):
7/22/2011 9:24:00 PM
Last edit date (GMT):
7/22/2011 9:24:00 PM
Show other editors
Incoming cross-relations:
0
Outgoing cross-relations:
0
Average rating:
0
by
0
users
Enter comment
Select article text to quote
Cancel
Enter
welcome text
First name
Last name
Email
Skip
Join
x
Select file to upload